Christine Bangert Selected Research

dichlorodimethylsilane (dimethyldichlorosilane)

12/2005

Dendritic cells in atopic dermatitis: expression of FcepsilonRI on two distinct inflammation-associated subsets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Bangert Research Topics

Disease

6	Atopic Dermatitis (Atopic Eczema) 01/2022 - 02/2011
4	Inflammation (Inflammations) 01/2022 - 12/2005
4	Nasal Polyps (Nasal Polyp) 01/2022 - 03/2020
3	Hypersensitivity (Allergy) 01/2022 - 03/2020
3	Rhinosinusitis 01/2022 - 03/2020
2	Asthma (Bronchial Asthma) 01/2022 - 01/2022
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 05/2015
2	Pemphigus (Pemphigus Vulgaris) 12/2017 - 05/2015
1	Necrotizing Pneumonia 07/2022
1	Drug Hypersensitivity (Drug Allergy) 07/2022
1	Aspirin-Induced Asthma 01/2022
1	Eosinophilia 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Polyps 01/2022
1	Dermatomyositis (Dermatopolymyositis) 02/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Blister (Bulla) 11/2020
1	Folliculitis (Sycosis) 04/2020
1	Eczema 04/2020
1	Rosacea (Acne Rosacea) 04/2020
1	Bullous Pemphigoid (Pemphigoid) 10/2019
1	Skin Diseases (Skin Disease) 10/2019
1	Syphilis 10/2019
1	Hyperplasia 01/2017
1	Acute Coronary Syndrome 01/2015
1	Myocardial Infarction 01/2015
1	Infarction (Infarctions) 01/2015
1	Thrombosis (Thrombus) 01/2015
1	Skin Neoplasms (Skin Cancer) 06/2007
1	Neoplasms (Cancer) 06/2007

Drug/Important Bio-Agent (IBA)

4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 03/2020
3	Biological ProductsIBA 01/2022 - 06/2007
3	AutoantibodiesIBA 10/2019 - 05/2015
2	Immunoglobulin E (IgE)IBA 01/2022 - 12/2005
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2020
2	CytokinesIBA 01/2022 - 01/2018
2	dupilumabIBA 01/2021 - 04/2020
2	Interleukin-23 Subunit p19IBA 01/2018 - 05/2015
2	Monoclonal AntibodiesIBA 01/2018 - 05/2015
2	Interleukin-23 (Interleukin 23)IBA 01/2018 - 05/2015
2	tildrakizumabIBA 01/2018 - 05/2015
2	DesmogleinsIBA 12/2017 - 05/2015
2	InterleukinsIBA 01/2017 - 05/2015
2	Interleukin-12 (IL 12)IBA 01/2017 - 05/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2022
1	Omalizumab (Xolair)FDA Link 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	bulevirtideIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	EnzymesIBA 01/2022
1	Niclosamide FDA Link 01/2022
1	Cyclooxygenase 1IBA 01/2022
1	MyostatinIBA 02/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 11/2020
1	AmphiregulinIBA 11/2020
1	Immunoglobulin A (IgA)IBA 04/2020
1	2-methyl-4-isothiazolin-3-oneIBA 03/2020
1	AntibodiesIBA 10/2019
1	Etanercept (Enbrel)FDA Link 01/2018
1	DesmocollinsIBA 12/2017
1	Protein Isoforms (Isoforms)IBA 12/2017
1	Ustekinumab (CNTO 1275)FDA Link 01/2017
1	Deoxyribonucleases (DNase)FDA Link 01/2015
1	pimecrolimus (Elidel)FDA Link 02/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2011
1	Imiquimod (Aldara)FDA LinkGeneric 06/2007
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2007
1	Granzymes (Granzyme)IBA 06/2007
1	dichlorodimethylsilane (dimethyldichlorosilane)IBA 12/2005

Therapy/Procedure

2	Therapeutics 01/2017 - 05/2015
1	Aftercare (After-Treatment) 01/2017
1	Thrombectomy 01/2015
1	Percutaneous Coronary Intervention 01/2015